LRRK2 mutations can cause familial and sporadic Parkinson's disease (PD) with Lewy-body pathology at post-mortem. Studies of olfaction in LRRK2 are sparse and incongruent. We applied a previously validated translation of the 16 item smell identification test from Sniffin' Sticks (SS-16) to 14 parkinsonian carriers of heterozygous G2019S LRRK2 mutation and compared with 106 PD patients and 118 healthy controls. the mean SS-16 score in LRRK2 was higher than in PD (p < 0.001, 95% CI for beta = -4.7 to -1.7) and lower than in controls (p = 0.007, 95% CI for beta = +0.6 to +3.6). in the LRRK2 group, subjects with low scores had significantly more dyskinesia. They also had younger age of onset, longer disease duration, and reported less frequentl...
Idiopathic Parkinson's disease (IPD) and LRRK2-associated PD (LRRK2-PD) might be expected to differ ...
Background: Selective olfactory deficits occur in 70% to 90% of patients with Parkinson disease, ind...
Background: Idiopathic Parkinson's disease (IPD) and LRRK2-associated PD (LRRK2-PD) might be expecte...
LRRK2 mutations can cause familial and sporadic Parkinson's disease (PD) with Lewy-body pathology at...
Background: Mutations in PARK8 (LRRK2) are associated with autosomal dominant parkinsonism and Parki...
ObjectiveOlfactory impairment is a potential marker for impending phenoconversion to Parkinson disea...
OBJECTIVE: To evaluate the relation between olfactory impairment (OI) and other impairment domains i...
Objective: To evaluate the relation between olfactory impairment (OI) and other impairment domains i...
Hyposmia is a common nonmotor symptom in Parkinson's disease (PD) and has been variably detected in ...
Olfactory dysfunction is associated with normal aging, multiple neurodegenerative disorders, includi...
Hyposmia is a common nonmotor feature of Parkinson's disease (PD) and has been variably detected in ...
This thesis examines the clinical and pathological involvement of the olfactory system in Parkinson...
BackgroundOlfactory dysfunction in Parkinson's disease (PD) is well-established and may represent on...
Hyposmia is a common nonmotor feature of Parkinson's disease (PD) and has been variably detected in ...
Background: Olfactory dysfunction in Parkinson\u27s disease (PD) is well-established and may represe...
Idiopathic Parkinson's disease (IPD) and LRRK2-associated PD (LRRK2-PD) might be expected to differ ...
Background: Selective olfactory deficits occur in 70% to 90% of patients with Parkinson disease, ind...
Background: Idiopathic Parkinson's disease (IPD) and LRRK2-associated PD (LRRK2-PD) might be expecte...
LRRK2 mutations can cause familial and sporadic Parkinson's disease (PD) with Lewy-body pathology at...
Background: Mutations in PARK8 (LRRK2) are associated with autosomal dominant parkinsonism and Parki...
ObjectiveOlfactory impairment is a potential marker for impending phenoconversion to Parkinson disea...
OBJECTIVE: To evaluate the relation between olfactory impairment (OI) and other impairment domains i...
Objective: To evaluate the relation between olfactory impairment (OI) and other impairment domains i...
Hyposmia is a common nonmotor symptom in Parkinson's disease (PD) and has been variably detected in ...
Olfactory dysfunction is associated with normal aging, multiple neurodegenerative disorders, includi...
Hyposmia is a common nonmotor feature of Parkinson's disease (PD) and has been variably detected in ...
This thesis examines the clinical and pathological involvement of the olfactory system in Parkinson...
BackgroundOlfactory dysfunction in Parkinson's disease (PD) is well-established and may represent on...
Hyposmia is a common nonmotor feature of Parkinson's disease (PD) and has been variably detected in ...
Background: Olfactory dysfunction in Parkinson\u27s disease (PD) is well-established and may represe...
Idiopathic Parkinson's disease (IPD) and LRRK2-associated PD (LRRK2-PD) might be expected to differ ...
Background: Selective olfactory deficits occur in 70% to 90% of patients with Parkinson disease, ind...
Background: Idiopathic Parkinson's disease (IPD) and LRRK2-associated PD (LRRK2-PD) might be expecte...